Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELACESTRANT for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where ELACESTRANT was used for Neoplasm malignant.

Most Reported Side Effects for ELACESTRANT

Side Effect Reports % Deaths Hosp.
Nausea 1,454 21.0% 22 137
Fatigue 1,081 15.6% 13 101
Disease progression 777 11.2% 9 45
Vomiting 662 9.6% 21 101
Diarrhoea 540 7.8% 7 56
Death 499 7.2% 499 66
Drug ineffective 478 6.9% 4 40
Constipation 389 5.6% 5 42
Product dose omission issue 364 5.3% 9 102
Decreased appetite 363 5.2% 8 51
Pain 361 5.2% 7 49
Arthralgia 325 4.7% 3 16
Asthenia 239 3.5% 9 50
Abdominal discomfort 230 3.3% 3 27
Dyspepsia 230 3.3% 2 22

Other Indications for ELACESTRANT

Product used for unknown indication (6,377) Breast cancer female (261) Breast cancer metastatic (226) Breast cancer (57) Hormone receptor positive her2 negative breast cancer (9) Metastases to bone (5)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

ELACESTRANT Full Profile All Neoplasm malignant Drugs ELACESTRANT Demographics ELACESTRANT Timeline